Mayne Pharma reported AUD90.44M in Selling and Administration Expenses for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Ansell ANN:AU USD 200.5M 11.2M
Cochlear COH:AU AUD 355.8M 53.9M
CSL CSL:AU USD 900.7M 152.7M
Ecofibre Ltd EOF:AU AUD 11.21M 139K
Healius Ltd HLS:AU AUD 541.5M 43.6M
Integral Diagnostics Ltd IDX:AU AUD 111.52M 3.96M
Medical Developments International Ltd MVP:AU AUD 13.11M 4.29M
Nanosonics Ltd NAN:AU AUD 36.21M 4.26M
Next Science Ltd NXS:AU USD 7.98M 1.33M
Polynovo Ltd PNV:AU AUD 19.49M 7.16M
Probiotec Ltd PBP:AU AUD 13.95M 228.55K
Ramsay Health Care RHC:AU AUD 4.35B 398.7M
ResMed RMD:AU USD 194.89M 12.49M
Sigma Healthcare Ltd SIG:AU AUD 148.5M 10.53M
Sonic Healthcare SHL:AU AUD 2.21B 139.2M
Telix Pharmaceuticals Ltd TLX:AU AUD 49.39M 19.56M